A successful tale of sirolimus treatment in refractory vascular tumors
Sirolimus use in vascular tumors is limited. We present two cases of refractory vascular tumors with impressive response to sirolimus, one with refractory kaposiform hemangioendothelioma with rapid reversal of thrombocytopenia and heart failure and the other with advanced beard distribution hemangio...
Main Authors: | Iman Ahmed Ragab, Salwa Mostafa Abdel-Kader, Amr AbdelHamid AbouZeid, Shaimaa AbdelSattar Mohammad, Heba Gomaa Abdel Raheem, Nihal Hussien Aly |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Journal of Pediatric Surgery Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213576622000070 |
Similar Items
-
Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
by: Trevor B. Cabrera, et al.
Published: (2020-10-01) -
Commentary: Transarterial Embolization in Neonatal Kasabach–Merritt Syndrome
by: Huaijie Wang, et al.
Published: (2022-06-01) -
Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon successfully treated with sirolimus: A case report and literature review on pharmacological treatment
by: Enrique G. Villarreal, et al.
Published: (2023-03-01) -
Efficacy of transcatheter arterial chemoembolization combined with sirolimus for treating Kasabach–Merritt phenomenon in infants, a retrospective study
by: Chuan-gao Yin, et al.
Published: (2023-12-01) -
Pancreatic Kaposiform Hemangioendothelioma Not Responding to Sirolimus
by: Paloma Junco Triana, et al.
Published: (2017-01-01)